BMS-345541 Hydrochloride: Selective IKK/NF-κB Inhibitor for Cancer and Inflammation Research

Executive Summary: BMS-345541 hydrochloride (SKU A3248) is a small molecule inhibitor that selectively targets IKK-1 and IKK-2, blocking NF-κB pathway activation with IC₅₀ values of 4 μM and 0.3 μM, respectively (APExBIO). It inhibits the phosphorylation of IκBα, thereby reducing transcription of pro-inflammatory cytokines TNFα, IL-1β, IL-6, and IL-8 (Du et al., 2021). BMS-345541 demonstrates 100% oral bioavailability and efficacy in vivo, including significant reduction of TNFα production in mouse models. It induces apoptosis and G2/M cell cycle arrest in T-cell acute lymphoblastic leukemia (T-ALL) cells, supporting its use in cancer biology and chemoresistance research. The compound is water-soluble at ≥60 mg/mL and retains selectivity, minimizing off-target kinase effects.

Biological Rationale

The IKK/NF-κB pathway is a central regulator of inflammation, immune response, and cell survival. Aberrant NF-κB activation is implicated in chronic inflammatory diseases and cancer, particularly in hematological malignancies such as T-cell acute lymphoblastic leukemia (T-ALL) (Du et al., 2021). IKK complex-mediated phosphorylation of IκBα leads to its degradation, allowing NF-κB translocation to the nucleus and transcriptional activation of pro-survival and pro-inflammatory genes. Selective inhibition of IKK-1 and IKK-2 by BMS-345541 disrupts this signaling cascade, providing a strategic intervention point for experimental modulation of inflammation and cancer cell fate (Tolrestatsupply, 2023).

Mechanism of Action of BMS-345541 hydrochloride

BMS-345541 hydrochloride functions as an allosteric inhibitor of the IKK complex, binding selectively to IKK-1 and IKK-2 subunits (APExBIO). The compound blocks IKK-catalyzed phosphorylation of IκBα, preventing its degradation. This inhibits nuclear translocation of NF-κB and subsequently downregulates transcription of target pro-inflammatory cytokines (TNFα, IL-1β, IL-6, IL-8). BMS-345541 shows minimal activity against other serine/threonine and tyrosine kinases at concentrations effective for IKK inhibition, reducing off-target effects.

In vitro, BMS-345541 suppresses stimulus-induced IκBα phosphorylation and NF-κB target gene expression. In vivo, oral administration yields 100% bioavailability, with significant reduction of inflammatory cytokine levels in murine models. The compound induces apoptosis and G2/M phase cell cycle arrest in T-ALL cell lines, suggesting its utility for studying mechanisms of chemoresistance and cell death in hematological cancers (Peptone-bacteriological, 2023).

Evidence & Benchmarks

• BMS-345541 hydrochloride selectively inhibits IKK-1 (IC₅₀ = 4 μM) and IKK-2 (IC₅₀ = 0.3 μM) in enzyme assays (APExBIO).
• Inhibition of IKK prevents phosphorylation of IκBα, leading to reduced NF-κB nuclear activity in cell-based assays (Du et al., 2021).
• Reduces production of TNFα, IL-1β, IL-6, and IL-8 in vitro and in vivo (Du et al., 2021).
• Demonstrates 100% oral bioavailability in murine models, with significant reduction of TNFα after systemic inflammatory challenge (APExBIO).
• Induces apoptosis and G2/M cell cycle arrest in T-ALL cell lines, highlighting its role in cancer biology and chemoresistance studies (Peptone-bacteriological, 2023).
• Shows minimal inhibition of unrelated kinases (e.g., MAPKs, PI3K, CDKs) at working concentrations, ensuring selectivity (APExBIO).

Applications, Limits & Misconceptions

BMS-345541 hydrochloride is widely utilized in:

• Inflammation research: Dissecting NF-κB pathway contributions to cytokine production.
• Cancer biology: Studying apoptosis, cell cycle arrest, and overcoming chemoresistance in T-ALL and other malignancies.
• Cell signaling: Mapping IKK/NF-κB pathway effects on gene transcription and cell fate decisions.
• In vivo pharmacology: Evaluating anti-inflammatory and anti-tumor effects in animal models.

For an extended protocol-driven discussion of cell assay optimization and troubleshooting, see this evidence-driven guide, which this article updates with new mechanistic and selectivity data.

Common Pitfalls or Misconceptions

• BMS-345541 is not a pan-kinase inhibitor: It does not broadly inhibit other kinase families at effective concentrations.
• Solubility is context-dependent: Although highly water-soluble, it is insoluble in ethanol and DMSO at room temperature; warming and sonication are required for DMSO stock preparation.
• Does not reverse established NF-κB-driven pathology: Its effects are preventive or modulatory, not curative, in chronic disease models.
• Not suitable for long-term storage in solution: Stability decreases over extended periods, especially at room temperature.
• Cellular effects are context- and dosage-dependent: Effects on apoptosis and cell cycle vary with cell type and concentration; optimization is required.

Workflow Integration & Parameters

BMS-345541 hydrochloride (from APExBIO) is provided as a water-soluble powder (product page). For experimental use, prepare stock solutions at concentrations up to 60 mg/mL in water; for DMSO stocks, warming and sonication are recommended. Typical working concentrations range from 0.04 to 100 μM, depending on the assay. Store at -20°C and avoid repeated freeze-thaw cycles or long-term storage in solution. In cell-based and in vivo assays, titrate concentrations to minimize cytotoxicity unrelated to IKK inhibition. For troubleshooting and workflow optimization, see this application-focused article, which this review extends by highlighting selectivity and mechanistic benchmarks.

Conclusion & Outlook

BMS-345541 hydrochloride offers precise, selective inhibition of the IKK/NF-κB axis, with strong supporting evidence for its use in inflammation and cancer biology research. Its robust oral bioavailability and high aqueous solubility make it a practical choice for diverse experimental designs. By minimizing off-target effects and enabling reproducible modulation of key signaling pathways, BMS-345541 supports advanced mechanistic studies into cytokine regulation, apoptosis, and chemoresistance. For further reading on the molecular context of NF-κB pathway inhibition, see this pathway-focused review, which this article expands upon with updated evidence and workflow parameters.